Share

September 29, 2020; 95 (13) Special Editorial

Long-Haul COVID

Avindra Nath
First published August 11, 2020, DOI: https://doi.org/10.1212/WNL.0000000000010640
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
11207

Share

Article Information

vol. 95 no. 13 559-560
DOI: 
https://doi.org/10.1212/WNL.0000000000010640
PubMed: 
32788251
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published August 11, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Avindra Nath, MD
  1. Avindra Nath, MD
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Associate Editor, Journal of Neurovirology Editor, Practice Neurology Section Editor, Frontiers in Neurology

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH intramural funds

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the National Institutes of Health, Bethesda, MD.
  1. Correspondence
    Dr. Nath natha{at}ninds.nih.gov
View Full Text

Article usage

Article usage: August 2020 to April 2023

AbstractFullPdfSource
Aug 2020001462Highwire
Sep 20207672667Highwire
Oct 20201411368982Highwire
Nov 2020144658411Highwire
Dec 20201251076418Highwire
Jan 20211561474540Highwire
Feb 20211361084459Highwire
Mar 20211801317553Highwire
Apr 2021161993464Highwire
May 20211011061391Highwire
Jun 202171809306Highwire
Jul 2021122686296Highwire
Aug 2021115747340Highwire
Sep 2021199656432Highwire
Oct 2021134784346Highwire
Nov 202179540271Highwire
Dec 202187624237Highwire
Jan 2022116696405Highwire
Feb 2022111515418Highwire
Mar 2022102399232Highwire
Apr 202258278195Highwire
May 202271326179Highwire
Jun 202253212124Highwire
Jul 202265298120Highwire
Aug 202246177123Highwire
Sep 202280274117Highwire
Oct 202263294131Highwire
Nov 202271275122Highwire
Dec 202225238114Highwire
Jan 20233519496Highwire
Feb 20233216477Highwire
Mar 20232720676Highwire
Apr 202317118103Highwire

Cited By...

Letters: Rapid online correspondence

  • Reader Response: Long-Haul COVID
    • Marylou V Solbrig, Professor of Medicine (Neurology) and Medical Microbiology (retired), University of Manitoba
    Submitted November 30, 2020
  • Reader response: Long-Haul COVID
    • Jon Stone, Professor of Neurology, Centre of Clinical Brain Sciences, University of Edinburgh (Edinburgh, UK)
    • Alan Carson, Professor of Neuropsychiatry, Centre of Clinical Brain Sciences, University of Edinburgh (Edinburgh, UK)
    Submitted September 29, 2020
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me

Recommended articles